As such, the results demonstrate that our oral gel platform enhances the delivery of lipophilic cannabinoid molecules and delivers more efficient uptake in the body. These results create a clear ...

A crowdfunded study found that all 131 drugs tested met all quality standards. This contradicts even the official data on ...

A new study links higher weekly THC intake to an increased risk of cannabis use disorder in young people. Researchers suggest ...

Bacterial Conjunctivitis Drugs Market is expected to reach US$ 4.9 Billion by 2036, Driven by Increasing Prevalence of Eye ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS (TM), a multimodal AI model that achieves state-of-the-art ...

1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS™, a multimodal AI model that achieves state-of-the-art accuracy ...

It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. -- Surrogate assays are a breakthrough for AI model training. 1910 ...